Endocannabinoid influence in alcohol dependence-related HPA axis dysregulation

内源性大麻素对酒精依赖相关 HPA 轴失调的影响

基本信息

  • 批准号:
    9191289
  • 负责人:
  • 金额:
    $ 0.84万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-01-01 至 2017-01-31
  • 项目状态:
    已结题

项目摘要

Project Summary The current project supports the postdoctoral fellow applicant in expanding her technical skills to include in vivo investigations of neurochemical processes during behavioral and pharmacological treatment, as well as ex vivo examination of enzyme activity and receptor coupling. In addition, the applicant will learn analytical chemistry techniques with which to examine these data, including liquid chromatography mass spectrometry (LC-MS), activity based protein profiling (ABPP) and [35S]GTPγS binding. These techniques will be employed in the current proposal, which investigates the effects of stress and protracted alcohol withdrawal on endocannabinoid (eCB) regulation of hypothalamic-pituitary-adrenal (HPA) axis activity and voluntary alcohol consumption. Aim 1 of this proposal targets dysregulation of the eCB system (including catabolizing enzymes and cannabinoid 1 receptor (CB1) binding), GABA release, and HPA responsivity following chronic intermittent ethanol (CIE) vapor exposure. The region of interest in the current studies is the prelimbic (PrL) division of the medial prefrontal cortex since this area exerts top-down control over HPA activity and cognitive behaviors associated with imminent relapse. The second Aim is designed to examine how eCB activity in the PrL affects voluntary alcohol consumption in protracted alcohol withdrawal. The proposed studies will require the applicant to receive extensive methodological training in neurochemical data collection, analysis and interpretation and will support the applicant's overall goal of examining novel therapeutic targets for the treatment of psychiatric illness and alcohol addiction. Furthermore, the applicant's sponsor is highly regarded and successful in the alcohol and eCB fields, and possesses both the fiscal and material resources to support the applicant during the fellowship period. The Scripps Research Institute (TSRI) is an ideal institution for providing additional training and resources to the applicant outside of the laboratory. Departmental meetings as well as meetings of TSRI's Alcohol Research Center (ARC) impart invaluable experience towards participation in research and development goals of the institute, and towards networking in an interdisciplinary and collaborative environment. Additionally, TSRI is committed to promoting the highest standards of the responsible conduct of research, and has partnered with UC San Diego to provide several opportunities towards furthering the applicant's education in these fields. Through these exemplary training opportunities at TSRI, the applicant will be well supported to examine the novel studies proposed in this application.
项目摘要 当前的项目支持博士后同伴将她的技术技能扩展到 包括对行为和药物治疗过程中神经化学过程的体内研究, 以及对酶活性和接收器偶联的体内检查。此外,申请人将学习 分析化学技术可以检查这些数据,包括液相色谱质量 光谱法(LC-MS),基于活性的蛋白质分析(ABPP)和[35S]GTPγS结合。这些技术会 在当前的提案中使用,该提案研究了压力和受保护的专辑的影响 在内源性大麻素(ECB)调节下丘脑 - 垂体 - 肾上腺(HPA)轴活动和自愿性 饮酒。该提案的目标1针对欧洲央行系统的失调(包括分解代谢 慢性后,酶和大麻素1受体(CB1)结合),GABA释放和HPA反应性 间歇性乙醇(CIE)蒸气暴露。当前研究中感兴趣的区域是预临时(PRL) 媒体前额叶皮层的划分,因为该区域对HPA活动进行自上而下的控制 与即将退休有关的行为。第二个目的旨在研究欧洲央行的活动 PRL会影响长期饮酒的自愿饮酒。拟议的研究将需要 申请人接受神经化学数据收集,分析和 解释,并将支持申请人检查新颖的治疗靶标的总体目标 治疗精神病和酗酒。此外,申请人的赞助商受到高度评价 并在酒精和欧洲央行领域取得成功,并拥有财政和物质资源以支持 申请人在奖学金期间。 Scripps研究所(TSRI)是一个理想的机构 向实验室以外的申请人提供额外的培训和资源。部门会议 以及TSRI酒精研究中心(ARC)的会议赋予参与的宝贵经验 研究所的研究和发展目标,以及在跨学科和 协作环境。此外,TSRI致力于提升最高标准 负责任的研究进行,并与加州大学圣地亚哥分校合作提供了一些机会 旨在进一步在这些领域的教育。通过这些示例培训机会 TSRI,该应用程序将得到很好的支持,以检查本应用程序中提出的新研究。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Sarah A. Laredo其他文献

Sarah A. Laredo的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

Differential control of 2-AG’s activity at CB1R by ABHD6 and MAGL
ABHD6 和 MAGL 对 CB1R 上 2-AG 活性的差异控制
  • 批准号:
    10664172
  • 财政年份:
    2023
  • 资助金额:
    $ 0.84万
  • 项目类别:
Targeting the Endocannabinoid System for Headache Intervention
针对内源性大麻素系统进行头痛干预
  • 批准号:
    10584948
  • 财政年份:
    2023
  • 资助金额:
    $ 0.84万
  • 项目类别:
Effect of a potent and metabolically stable endocannabinoid receptor agonist on inflammasome-induced neuroinflammation in a comorbid mouse model of Alzheimer's disease and HIV
一种有效且代谢稳定的内源性大麻素受体激动剂对阿尔茨海默病和艾滋病毒共病小鼠模型中炎症小体诱导的神经炎症的影响
  • 批准号:
    10285175
  • 财政年份:
    2020
  • 资助金额:
    $ 0.84万
  • 项目类别:
Novel PET Tracers for Imaging Monoacylglycerol Lipase in Endocannabinoid Signaling
用于内源性大麻素信号传导中单酰甘油脂肪酶成像的新型 PET 示踪剂
  • 批准号:
    9923963
  • 财政年份:
    2017
  • 资助金额:
    $ 0.84万
  • 项目类别:
Anti-Epileptic Action of ABHD6 Inhibitors as Treatment for Dravet Syndrome
ABHD6 抑制剂治疗 Dravet 综合征的抗癫痫作用
  • 批准号:
    9331065
  • 财政年份:
    2017
  • 资助金额:
    $ 0.84万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了